Latest Insider Transactions at Unity Biotechnology, Inc. (UBX)
This section provides a real-time view of insider transactions for Unity Biotechnology, Inc. (UBX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Unity Biotechnology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Unity Biotechnology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2021
|
Lynne Marie Sullivan CFO & Head of Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
30,833
+10.22%
|
-
|
|
Jun 24
2021
|
Alexander Hieu Nguyen Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+50.0%
|
-
|
|
Jun 21
2021
|
Jamie Dananberg Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,515
-0.51%
|
$14,060
$4.18 P/Share
|
|
Mar 30
2021
|
Jamie Dananberg Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,393
-3.06%
|
$173,572
$4.34 P/Share
|
|
Jan 29
2021
|
Anirvan Ghosh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+22.73%
|
-
|
|
Dec 16
2020
|
Nathaniel E David |
SELL
Open market or private sale
|
Direct |
1,700,000
-73.13%
|
$8,500,000
$5.24 P/Share
|